发明名称 |
Tranexamic acid formulations |
摘要 |
Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith. |
申请公布号 |
US8791160(B2) |
申请公布日期 |
2014.07.29 |
申请号 |
US201213620226 |
申请日期 |
2012.09.14 |
申请人 |
Ferring B.V. |
发明人 |
Moore Keith A.;Heasley Ralph A.;Greiwe Jeffrey S.;Facemire John W.;Modest Jason D. |
分类号 |
A61K31/19;A61K31/195;A61K31/196;A61K9/20 |
主分类号 |
A61K31/19 |
代理机构 |
Fish & Richardson P.C. |
代理人 |
Fish & Richardson P.C. |
主权项 |
1. A tranexamic acid tablet formulation comprising:
tranexamic acid or a pharmaceutically acceptable salt thereof; and a modified release material; wherein the tranexamic acid or pharmaceutically acceptable salt thereof is present in an amount from about 50% to about 95% by weight of the formulation; wherein the modified release material is present in an amount from about 5% to about 50% by weight of the formulation; and wherein said tablet formulation provides an in-vitro dissolution release rate of the tranexamic acid or pharmaceutically acceptable salt thereof, when measured by a USP 27 Apparatus Type II Paddle Method @ 50 RPM in 900 ml water at 37±0.5° C., of less than about 70% by weight of the tranexamic acid or pharmaceutically acceptable salt thereof released at about 45 minutes, and about 100% by weight of the tranexamic acid or pharmaceutically acceptable salt thereof released at about 120 minutes. |
地址 |
Hoofddorp NL |